The DOI matches its Crossref record; 161 of the 162 references it cites were found in a registry or an index.
Metabolic Syndrome-Related Kidney Injury: A Review and Update
Open accessAbstract
Metabolic syndrome (MetS) includes visceral obesity, hyperglycemia, dyslipidemia, and hypertension. The prevalence of MetS is 20-25%, which is an important risk factor for chronic kidney disease (CKD). MetS causes effects on renal pathophysiology, including glomerular hyperfiltration, RAAS, microalbuminuria, profibrotic factors and podocyte injury. This review compares several criteria of MetS and analyzes their differences. MetS and the pathogenesis of CKD includes insulin resistance, obesity, dyslipidemia, inflammation, oxidative stress, and endothelial dysfunction. The intervention of MetS-related renal damage is the focus of this article and includes controlling body weight, hypertension, hyperglycemia, and hyperlipidemia, requiring all components to meet the criteria. In addition, interventions such as endoplasmic reticulum stress, oxidative stress, gut microbiota, body metabolism, appetite inhibition, podocyte apoptosis, and mesenchymal stem cells are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although the study was not designed to examine mechanism(s) underlying CVD risk reduction in CKM, cardioprotective properties of EPA that offset inflammation and oxidative stress while improving endothelial function may have been operative in this high-risk phenotype [[15], [16], [17], [18]].”
From Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM (2026) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647 · cited 1×
“Liraglutide is a widely used GLP-1 receptor agonist, which has definite efficacy in reducing plaque formation and antiatherosclerotic action (141).”
BackgroundMetabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,199
Moore, J. X., Chaudhary, N. S., & Akinyemiju, T. (2017) · Preventing Chronic Disease · doi:10.5888/pcd14.160287 · Cited by 940
Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016
Hirode, G., & Wong, R. J. (2020) · JAMA · doi:10.1001/jama.2020.4501 · Cited by 936
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 735
Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608249103 · Cited by 711
Glomerular hyperfiltration: definitions, mechanisms and clinical implications
Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B., & Schrier, R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.19 · Cited by 673
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Rossi, J. L. S., Barbalho, S. M., de Araújo, R. R., Bechara, M. D., Sloan, K. P., & Sloan, L. A. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3502 · Cited by 606
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02180311 · Cited by 553
Obesity, hypertension, and chronic kidney disease
Hall, J., Juncos, L., Wang, Z., Hall, M., do Carmo, J., & da Silva, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39739 · Cited by 520
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease
Remuzzi, G., Perico, N., Macia, M. L., & Ruggenenti, P. L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09911.x · Cited by 513
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.015 · Cited by 468
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.066 · Cited by 392
Quercetin and metabolic syndrome: A review
Hosseini, A., Razavi, B. M., Banach, M., & Hosseinzadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7144 · Cited by 390
Weight Loss Interventions in Chronic Kidney Disease
Navaneethan, S. D., Yehnert, H., Moustarah, F., Schreiber, M. J., Schauer, P. R., & Beddhu, S. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02250409 · Cited by 389
Prevalence of metabolic syndrome in mainland china: a meta-analysis of published studies
Li, R., Li, W., Lun, Z., Zhang, H., Sun, Z., Kanu, J. S., Qiu, S., Cheng, Y., & Liu, Y. (2016) · BMC Public Health · doi:10.1186/s12889-016-2870-y · Cited by 369
Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism
Bertolio, R., Napoletano, F., Mano, M., Maurer‐Stroh, S., Fantuz, M., Zannini, A., Bicciato, S., Sorrentino, G., & Sal, G. D. (2019) · Nature Communications · doi:10.1038/s41467-019-09152-7 · Cited by 304
Muñoz‐Durango, N., Fuentes, C., Castillo, A., González-Gómez, L. M., Vecchiola, A., Fardella, C., & Kalergis, A. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17070797 · Cited by 297
Leptin Function and Regulation
Zhang, Y., & Chua, S. C. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160041 · Cited by 284
Metabolic Syndrome and Risk of Acute Myocardial Infarction
Mente, A., Yusuf, S., Islam, S., McQueen, M., Tanomsup, S., Onen, C. L., Rangarajan, S., Gerstein, H. C., & Anand, S. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.053 · Cited by 261
Yvan‐Charvet, L., & Quignard‐Boulangé, A. (2010) · Kidney International · doi:10.1038/ki.2010.391 · Cited by 221
Bernini, L. J., Simão, A. N. C., Alfieri, D. F., Lozovoy, M. A. B., Mari, N. L., de Souza, C. H. B., Dichi, I., & Costa, G. N. (2015) · Nutrition · doi:10.1016/j.nut.2015.11.001 · Cited by 212
Immunologic and endocrine functions of adipose tissue: implications for kidney disease
Zhu, Q., & Scherer, P. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.157 · Cited by 200
Impact of different ectopic fat depots on cardiovascular and metabolic diseases
Ferrara, D., Montecucco, F., Dallegri, F., & Carbone, F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28821 · Cited by 195
Bariatric surgery is associated with improvement in kidney outcomes
Chang, A. R., Chen, Y., Still, C. D., Wood, G. C., Kirchner, H. L., Lewis, M. W., Kramer, H., Hartle, J. E., Carey, D. J., Appel, L. J., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.039 · Cited by 185
Athyros, V. G., Mikhailidis, D. P., Liberopoulos, E. N., Kakafika, A. I., Karagiannis, A. I., Papageorgiou, A. A., Τζιόμαλος, Κ., Ganotakis, E. S., & Elisaf, M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl538 · Cited by 181
The Renin Angiotensin Aldosterone System in Obesity and Hypertension
Cabandugama, P. K., Gardner, M. J., & Sowers, J. R. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.009 · Cited by 168
Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction
Gu, P., & Xu, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9230-8 · Cited by 160
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
Rizzo, M., Nikolic, D., Patti, A. M., Mannina, C., Montalto, G., McAdams, B. S., Rizvi, A. A., & Cosentino, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.012 · Cited by 152
Metabolic Syndrome and the Development of CKD in American Indians: The Strong Heart Study
Lucove, J. C., Vupputuri, S. X., HEISS, G. M., North, K. E., & Russell, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.09.014 · Cited by 148
Lopes, H. F., Corrêa‐Giannella, M. L., Consolim‐Colombo, F. M., & Egan, B. M. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0156-2 · Cited by 147
Urinary Podocyte Microparticles Identify Prealbuminuric Diabetic Glomerular Injury
Burger, D. E., Thibodeau, J.-F., Holterman, C. E., Burns, K. D., Touyz, R. M., & Kennedy, C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070763 · Cited by 142
Characteristics of healthy vascular ageing in pooled population-based cohort studies
Nilsson, P. M., Laurent, S., Cunha, P., Olsen, M. H., Rietzschel, E. R., Franco, O. H., Ryliškytė, L., Strazhesko, I. D., Vlachopoulos, C. V., Chen, C., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001824 · Cited by 132
Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension
Mair, K. M., Gaw, R., & MacLean, M. R. (2020) · Pulmonary Circulation · doi:10.1177/2045894020952023 · Cited by 129
Metabolic syndrome and stroke: A meta-analysis of prospective cohort studies
Li, X., Li, X., Lin, H., Fu, X., Lin, W., Li, M., Zeng, X., & Gao, Q. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.01.018 · Cited by 125
Straznicky, N. E., Grima, M. T., Lambert, É., Eikelis, N., Dawood, T., Lambert, G. W., Nestel, P. J., Masuo, K., Sari, C. I., Chopra, R., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283418875 · Cited by 123
Zibadi, S., Rohdewald, P. J., Park, D., & WATSON, R. R. (2008) · Nutrition Research · doi:10.1016/j.nutres.2008.03.003 · Cited by 119
The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort.
Kitiyakara, C., Yamwong, S., Cheepudomwit, S., Domrongkitchaiporn, S., Unkurapinun, N., Pakpeankitvatana, V., & Sritara, P. (2007) · Kidney International · doi:10.1038/sj.ki.5002128 · Cited by 113
Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites
Croci, S., D'Apolito, L. I., Gasperi, V., Catani, M. V., & Savini, I. (2021) · Nutrients · doi:10.3390/nu13051389 · Cited by 111
Prevalence and risk factors of metabolic syndrome among Asian Indians: A community survey
Ravikiran, M., Bhansali, A. K., Ravikumar, P., Bhansali, S., Dutta, P. R., Thakur, J. S., Sachdeva, N. K., Bhadada, S. K., & Walia, R. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.010 · Cited by 110
Moy, F. M., & Bulgiba, A. M. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-678 · Cited by 109
Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional Study
Alexander, M. P., Patel, T. V., Farag, Y. M. K., Flórez, A., Rennke, H. G., & Singh, A. K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.01.255 · Cited by 107
Anagnostis, P. G., Katsiki, N., Adamidou, F., Athyros, V. G., Karagiannis, A. I., Kita, M. D., & Mikhailidis, D. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.002 · Cited by 107
Och, A., Och, M., Nowak, R., Podgórska, D., & Podgórski, R. (2022) · Molecules · doi:10.3390/molecules27041351 · Cited by 104
Hypertension in Metabolic Syndrome: Novel Insights
Katsimardou, A., Imprialos, K. P., Stavropoulos, K., Sachinidis, A. G., Doumas, M. N., & Athyros, V. G. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190415161813 · Cited by 103
Hydrie, M. Z. I., Shera, A. S., Fawwad, A., Basit, A., & Hussain, A. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0055 · Cited by 90
Metabolic Syndrome, ESRD, and Death in CKD
Navaneethan, S. D., Schold, J. D., Kirwan, J. P., Arrigain, S., Jolly, S. E., Poggio, E. D., Beddhu, S., & Nally, J. V. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09870912 · Cited by 86
Kidney outcomes three years after bariatric surgery in severely obese adolescents
Nehus, E. J., Khoury, J. C., Inge, T. H., Xiao, N., Jenkins, T. M., Moxey‐Mims, M., & Mitsnefes, M. M. (2016) · Kidney International · doi:10.1016/j.kint.2016.09.031 · Cited by 86
Childhood Obesity and the Metabolic Syndrome
Nehus, E. J., & Mitsnefes, M. M. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.08.004 · Cited by 84
Díaz-Flores, M., Cruz, M., Durán-Reyes, G., Munguía-Miranda, C., Loza‐Rodriguez, H., Pulido-Casas, E., Torres‐Ramírez, N., Gaja-Rodriguez, O., Kumate, J., Baiza-Gutman, L. A., et al. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0341 · Cited by 77
Fife, E., Kostka, J., Kroc, Ł., Guligowska, A., Pigłowska, M., Sołtysik, B. K., Kaufman‐Szymczyk, A., Fabianowska‐Majewska, K., & Kostka, T. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0888-y · Cited by 77
Pammer, L. M., Lamina, C., Schultheiß, U. T., Kotsis, F., Kollerits, B., Stockmann, H., Lipovsek, J., Meiselbach, H., Busch, M., Eckardt, K., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13355 · Cited by 76
Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia
Gilani, S. I., Anderson, U. D., Jayachandran, M., Weissgerber, T. L., Zand, L., White, W., Milic, N. M., Suarez, M. L. G., Vallapureddy, R. R., Nääv, Å., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111202 · Cited by 76
Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass
Aminian, A., Daigle, C. R., Romero‐Talamás, H., Kashyap, S. R., Kirwan, J. P., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.01.025 · Cited by 74
Physiological role of adiponectin in different tissues: a review
Esmaili, S., Hemmati, M., & Karamian, M. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1493606 · Cited by 73
Underlying Mechanisms of Renal Lipotoxicity in Obesity
Escasany, E., Izquierdo‐Lahuerta, A., & Medina‐Gómez, G. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000494694 · Cited by 73
Kidney function in metabolic syndrome may be improved with Pycnogenol®.
Stuard, S., Belcaro, G., Cesarone, M. R., Ricci, A., Dugall, M., Cornelli, U., Gizzi, G., Pellegrini, L., & Rohdewald, P. J. (2010) · PubMed · Cited by 72
Kang, S. H., Cho, K. H., Park, J. W., Yoon, K. W., & Do, J. Y. (2015) · Kidney and Blood Pressure Research · doi:10.1159/000368498 · Cited by 72
Chang, C., Ke, H., Lee, J., Lee, Y., Jhan, J., Wang, H.-S., Shen, J.-T., Tsao, Y.-H., Huang, S., & Geng, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111154 · Cited by 70
Lee, H., & José, P. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670076 · Cited by 68
Li, H., Li, M., Liu, P., Wang, Y., Zhang, H., Li, H., Yang, S.-F., Song, Y., Yin, Y., Gao, L., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07008 · Cited by 66
Mechanisms linking the renin-angiotensin system, obesity, and breast cancer
Rasha, F. A., Ramalingam, L., Gollahon, L., Rahman, R. L., Rahman, S. M., Menikdiwela, K. R., & Moustaïd‐Moussa, N. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0314 · Cited by 65
Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients
Kwon, S. H., Woollard, J. R., Saad, A., Garovic, V. D., Zand, L., Jordan, K. L., Textor, S. C., & Lerman, L. O. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw077 · Cited by 65
New Pandemic: Obesity and Associated Nephropathy
Sharma, I., Liao, Y., Zheng, X., & Kanwar, Y. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.673556 · Cited by 62
Impact of treating the metabolic syndrome on chronic kidney disease
Agrawal, V., Shah, A., Rice, C., Franklin, B. A., & McCullough, P. A. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.114 · Cited by 62
Ishii, M., Shibata, R., Kondo, K., Kambara, T., Shimizu, Y., Tanigawa, T., Bando, Y., Nishimura, M., Ouchi, N., & Murohara, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557835 · Cited by 61
Impact of adipose tissue in chronic kidney disease development (Review)
Miricescu, D., Bălan, D., Tulin, A. D., Ştiru, O., Văcăroiu, I. A., Mihai, D. A., Popa, C. O., Enyedi, M., Nedelea, A., Nica, A. E., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9969 · Cited by 61
Nasrallah, M., & Ziyadeh, F. N. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.005 · Cited by 60
From Obesity to Chronic Kidney Disease: How Can Adipose Tissue Affect Renal Function?
Martín-Taboada, M., Vila‐Bedmar, R., & Medina‐Gómez, G. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000515418 · Cited by 60
Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention
Yang, S., Cao, C., Deng, T., & Zhou, Z. (2020) · Kidney & Blood Pressure Research · doi:10.1159/000507784 · Cited by 60
Aihara, K., Ikeda, Y., Yagi, S., Akaike, M., & Matsumoto, T. (2010) · Cardiology Research and Practice · doi:10.4061/2011/175381 · Cited by 60
Canali, R., Comitato, R., Schönlau, F., & Virgili, F. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.06.001 · Cited by 60
Abdominal obesity and metabolic syndrome in South Asians: prevention and management
Jayawardena, R., Sooriyaarachchi, P., & Misra, A. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1982381 · Cited by 59
Alizadeh, S., Ahmadi, M., Nejad, B. G., Djazayeri, A., & Shab‐Bidar, S. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13201 · Cited by 56
Effects of glycine on metabolic syndrome components: a review
Imenshahidi, M., & Hossenzadeh, H. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01720-3 · Cited by 54
Cao, C., & Su, M. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7295 · Cited by 52
Association of Metabolic Syndrome With Kidney Function and Histology in Living Kidney Donors
Ohashi, Y., Thomas, G., Nurko, S., Stephany, B. R., Fatica, R. A., Chiesa, A., Rule, A. D., Srinivas, T. R., Schold, J. D., Navaneethan, S. D., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12369 · Cited by 51
Mende, C. W., & EINHORN, D. F. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0568 · Cited by 51
Metabolic syndrome severity score and the progression of CKD
Wu, M., Shu, Y., Wang, L., Song, L., Chen, S., Liu, Y., Bi, J., Li, D., Yang, Y., Hu, Y., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13646 · Cited by 50
Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study
DeBoer, M. D., Filipp, S. L., Musani, S. K., Sims, M., Okusa, M. D., & Gurka, M. J. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000488829 · Cited by 50
Kittiskulnam, P., Thokanit, N. S., Katavetin, P., Susanthitaphong, P., Srisawat, N., Praditpornsilpa, K., Tungsanga, K., & Eiam‐Ong, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196332 · Cited by 50
Xi, G., Shen, X., Wai, C., White, M. F., & Clemmons, D. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005398 · Cited by 49
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions
Tirandi, A., Carbone, F., Montecucco, F., & Liberale, L. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13693 · Cited by 48
Li, J., Li, J., Ni, J., Zhang, C., Jia, J., Wu, G., Sun, H., & Wang, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.752512 · Cited by 46
Lu, B., Zhong, J., Pan, J., Yuan, X., Ren, M., Jiang, L., Yang, Y., Zhang, G., Liu, D., & Zhang, C. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02166-1 · Cited by 44
Atherosclerotic-nephropathy: an updated narrative review
Simeoni, M., Borrelli, S., Garofalo, C., Fuíano, G., Esposito, C., Comi, A., & Provenzano, M. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00733-0 · Cited by 43
Cardiovascular and Renal Effects of Weight Reduction in Obesity and the Metabolic Syndrome
Cohen, J. B., & Cohen, D. L. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0544-2 · Cited by 42
Takamiya, T., Zaky, W. R., Edmundowics, D., Kadowaki, T., Ueshima, H., Kuller, L. H., & Sekikawa, A. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2977 · Cited by 42
Prakash, S., Rai, U., Kosuru, R., Tiwari, V. K., & Singh, S. (2019) · Biochimie · doi:10.1016/j.biochi.2019.11.005 · Cited by 42
Renoprotective role of bariatric surgery in patients with established chronic kidney disease
Morales, E., Porrini, E., Martín-Taboada, M., Lima, S. L., Vila‐Bedmar, R., de Pablos, I. G., Gómez, P., Rodríguez, E., Torres, L., Lanzón, B., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa266 · Cited by 41
Beneit, N., Fernandez‐Garcia, C. E., Martı́n-Ventura, J. L., Perdomo, L., Escribano, Ó., Michel, J., García-Gómez, G., Fernández, S., Díaz-Castroverde, S., Egido, J., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0477-3 · Cited by 40
Leptin and chronic kidney diseases
Mao, S., Li, F., Liu, F., Jiang, S., Wu, L., & Zhang, J. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1431278 · Cited by 39
Wu, N., Yao, Q., Chen, S., Yu, C., Xu, Y., Zhao, J., Yang, X., Li, N., & Pan, X. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3437 · Cited by 39
Self-citationSchnackenberg, C. G., Costell, M. H., Krosky, D. J., Cui, J., Wu, C. W., Hong, V. S., Harpel, M. R., Willette, R. N., & Yue, T.-L. (2013) · BioMed Research International · doi:10.1155/2013/427640 · Cited by 38
Zhang, L.-H., Zhu, X.-Y., Eirin, A., Nargesi, A. A., Woollard, J. R., Santelli, A., Sun, I. O., Textor, S. C., & Lerman, L. O. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00399.2018 · Cited by 37
Soofi, A. A., Wolf, K. I., Emont, M. P., Qi, N., Martinez-Santibañez, G., Grimley, E. C., Ostwani, W., & Dressler, G. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771428 · Cited by 36
Li, L., Yang, J., Li, F., Zhu, L., & Hao, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11872 · Cited by 34
Self-citationCardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic Dysfunction
Lau, E. S., Paniagua, S. M., Zarbafian, S., Hoffman, U., Long, M. T., Hwang, S., Courchesne, P. L., Yao, C., Ma, J., Larson, M. G., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020215 · Cited by 34
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease
Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2021) · American Journal of Nephrology · doi:10.1159/000518111 · Cited by 34
Ming, J., Xu, S., Yang, C., Gao, B., Wan, Y., Xing, Y., Zhang, L., Yang, W., & Ji, Q. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.004 · Cited by 34
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
Herat, L. Y., Matthews, J. R., Azzam, O., Schlaich, M. P., & Matthews, V. B. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01170-z · Cited by 31
Renal damage in the metabolic syndrome (MetSx): Disorders implicated
Joyce, T., Chirino, Y. I., Martínez‐Tagüeña, N., & Pedraza‐Chaverrí, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.032 · Cited by 30
Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes
Stutz, B., Ahola, A. J., Harjutsalo, V., Forsblom, C. M., & Groop, P. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.01.011 · Cited by 30
Sasaki, Y., Kohjimoto, Y., Iba, A., Matsumura, N., & Hara, I. (2015) · International Journal of Urology · doi:10.1111/iju.12691 · Cited by 29
Kawamoto, R., Akase, T., Ninomiya, D., Kumagi, T., & Kikuchi, A. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02320-0 · Cited by 29
Metabolic syndrome and Growth Differentiation Factor 15 in older adults
Carballo‐Casla, A., García‐Esquinas, E., Soto, A. B., Struijk, E. A., López‐García, E., Rodríguez‐Artalejo, F., & Ortolá, R. (2021) · GeroScience · doi:10.1007/s11357-021-00370-w · Cited by 29
Xing, Y., Xu, S., Jia, A., Cai, J., Zhao, M., Guo, J., Ji, Q., & Ming, J. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12578 · Cited by 28
Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes
Añón-Hidalgo, J., Catalán, V., Rodrı́guez, A., Ramírez, B., Silva, C., Galofré, J. C., Salvador, J., Frühbeck, G., & Gómez‐Ambrosi, J. (2019) · Aging · doi:10.18632/aging.101865 · Cited by 28
Stewart, L. K., & Kline, J. A. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201907-518oc · Cited by 28
Osthol Ameliorates Kidney Damage and Metabolic Syndrome Induced by a High-Fat/High-Sugar Diet
García‐Arroyo, F. E., Gonzaga, G., Tapia, E., Muñoz-Jiménez, I., Manterola-Romero, L., Osorio‐Alonso, H., Arellano-Buendía, A. S., Pedraza‐Chaverrí, J., Roncal-Jiménez, C. A., Lanaspa, M. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052431 · Cited by 28
Xi, G., Wai, C., White, M. F., & Clemmons, D. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.758987 · Cited by 27
Maldonado, M., Huang, T.-H., Yang, L.-J., Xu, L., & Ma, L. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0199-5 · Cited by 26
Ma, A., Liu, F., Wang, C., Liang, K., Yan, F., Hou, X., Liu, J., & Chen, L. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1934-6 · Cited by 26
Bruno, R. M., Reesink, K. D., & Ghiadoni, L. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.09.004 · Cited by 26
Owusu, J., & Barrett, E. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147574 · Cited by 25
Consequences of morbid obesity on the kidney. Where are we going?
Navarro-Díaz, M. (2016) · Clinical Kidney Journal · doi:10.1093/ckj/sfw094 · Cited by 24
Simple obesity and renal function.
Sikorska, D., Grzymisławska, M., Roszak, M., Gulbicka, P., Korybalska, K., & Witowski, J. (2017) · PubMed · Cited by 24
Marková, I., Miklánková, D., Hüttl, M., Kačer, P., Skibová, J., Kucera, J., Sedláček, R., Kačerová, T., Kazdová, L., & Malínská, H. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8712979 · Cited by 24
Incidence and correlation of metabolic syndrome and kidney stones in a healthy screening population
Qiu, F., Xu, Y., Ji, X., Pu, J., Zhou, J., & Huang, Y. (2021) · Translational Andrology and Urology · doi:10.21037/tau-21-689 · Cited by 24
Min, S. H., Kim, S., Jeong, I., Cho, H., Jeong, J., Lee, J., Kang, H., Kim, H.-S., Park, K. S., & Lim, S. K. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0200 · Cited by 22
Ramírez-Jiménez, M., Morales‐Palomo, F., Moreno‐Cabañas, A., Álvarez-Jiménez, L., ORTEGA, J. F., & Mora‐Rodríguez, R. (2021) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13949 · Cited by 22
Zhang, R., Sun, J., Wang, C., Wang, X., Zhao, P. Z., Yuan, Y., Hu, A. C., & Zhou, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.797183 · Cited by 22
Nagasawa, K., Matsuura, N., Takeshita, Y., Ito, S., Sano, Y., Yamada, Y., Uchinaka, A., Murohara, T., & Nagata, K. (2016) · Nutrition and Diabetes · doi:10.1038/nutd.2016.14 · Cited by 21
Oh, H., Jeong, K., Han, H. Y., Son, H. J., Kim, S. S., Lee, H. J., Kim, S., Sa, J. H., Jun, H., Ryu, J. H., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.042 · Cited by 19
Syauqy, A., Hsu, C., Lee, H.-A., Rau, H.-H., & Chao, J. C.-J. (2020) · Nutrients · doi:10.3390/nu13010040 · Cited by 19
Dapagliflozin, metformin, monotherapy or both in patients with metabolic syndrome
Cheng, L., Fu, Q.-Y., Zhou, L., Fan, Y., Liu, F.-F., Fan, Y.-Y., Zhang, X., Lin, W.-Z., & Wu, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-03773-z · Cited by 19
Fu, C.-P., Sheu, W., Lee, I., Lee, W.-J., Wang, J.-S., Liang, K.-W., Lee, W.-L., & Lin, S.-Y. (2015) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2014-0468 · Cited by 18
Velarde, G., Choudhary, N., Bravo‐Jaimes, K., Smotherman, C. R., Sherazi, S., & Kraemer, D. F. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.10.002 · Cited by 18
Rodríguez-Fierros, F. L., Guarner‐Lans, V., Soto, M. E., Manzano-Pech, L., Díaz‐Díaz, E., Soria‐Castro, E., Rubio-Ruiz, M. E., Jiménez-Trejo, F. J., & Pérez-Torres, I. (2021) · Molecules · doi:10.3390/molecules26072074 · Cited by 18
Çiçek, F. A., Zeynep, T.-K., Özçınar, E., Bozkuş, Y., Can, A. K., & Belma, T. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3392-2 · Cited by 17
Ng, H., Leung, F., Kuo, W., Lee, W., & Lee, C. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13574 · Cited by 16
Rodríguez‐Rodríguez, A. E., Donate‐Correa, J., Lima, S. L., Martin, L. D., Rodríguez, C., Pérez, J. A., Acosta, N. G., Fumero, C., Navarro-Díaz, M., López, D., et al. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001842 · Cited by 16
Malur, P., Menezes, A. R., DiNicolantonio, J. J., O’Keefe, J. H., & Lavie, C. J. (2017) · Europe PMC (PubMed Central) · Cited by 16
for the Saku Cohort Study Group, Morita, A., Aiba, N., Miyachi, M., & Watanabe, S. (2020) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-020-00250-w · Cited by 14
Eid, B. G., Neamatallah, T., Hanafy, A., El‐Bassossy, H. M., Binmahfouz, L. S., Aldawsari, H. M., Hasan, A., El-Aziz, G. S. A., Vemuri, K. V., & Makriyannis, A. (2021) · Molecules · doi:10.3390/molecules26040866 · Cited by 14
Uzu, T., NISHIMURA, M., Fujii, T., SAKAGUCHI, M., Kanasaki, M., Isshiki, K., Araki, S., Sugiomoto, T., Kashiwagi, A., & Kimura, G. (2007) · Hypertension Research · doi:10.1291/hypres.30.161 · Cited by 13
Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes
Vatier, C., Jéru, I., Fellahi, S., Capeau, J., Bastard, J., & Vigouroux, C. (2020) · Annales de biologie clinique · doi:10.1684/abc.2020.1551 · Cited by 11
Lin, J., Wu, H., Huang, W., Lu, C.-L., Cheng, M.-H., Wang, H.-T., Yen, T., & Wang, W. (2014) · Renal Failure · doi:10.3109/0886022x.2014.964140 · Cited by 11
Aljaylani, A., Fluitt, M. B., Piselli, A., Shepard, B. D., Tiwari, S., & ECELBARGER, C. A. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000248 · Cited by 11
Shamsuddin, S. A., Chan, A. M. L., Ng, M. H., Yazid, M. D., Law, J. X., Idrus, R. B. H., Fauzi, M. B., Yunus, M. H. M., & Lokanathan, Y. (2021) · PubMed Central · Cited by 10
Metabolic syndrome in children
Tagi, V. M., Samvelyan, S., & Chiarelli, F. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05834-x · Cited by 9
Serum growth differentiation factor 11 is closely related to metabolic syndrome in a Chinese cohort
Xu, B., Huang, Y., Zhang, R., Tang, M., He, Z., Jin, L., Zong, Y., Hu, C., & Jia, W. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13337 · Cited by 9
Masajtis‐Zagajewska, A., Majer, J., & Nowicki, M. P. (2021) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1155/2021/2214978 · Cited by 9
Moon, H., Ko, H., & Kim, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186810 · Cited by 8
Correia‐Costa, L., Morato, M., Sousa, T., Cosme, D., Guimarães, J. T., Guerra, A., Schaefer, F. S., Afonso, A. C., Azevedo, A., & Albino‐Teixeira, A. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3232-1 · Cited by 8
Stewart, L. K., Beam, D. M., Casciani, T., Cameron, S. J., & Kline, J. A. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.12.043 · Cited by 7
Association of metabolic syndrome traits with urinary biomarkers in Japanese adults
Kabasawa, K., Hosojima, M., Ito, Y., Matsushima, K., Tanaka, J., Hara, M., Nakamura, K., Narita, I., & Saito, A. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00779-5 · Cited by 7
Kagawa, T., Kozai, M., Masuda, M., Harada, N., Nakahashi, O., Tajiri, M., Yoshikawa, R., Nakao, M., Takei, Y., Iwano, M., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.058 · Cited by 5
Gonçalves, L. B., Miot, H. A., Domingues, M. A. C., & Oliveira, C. C. (2018) · Clinical Medicine Insights Pathology · doi:10.1177/1179555718791575 · Cited by 4
Farahani, R. A., Afarideh, M., Zhu, X., Tang, H. J., Jordan, K. L., Saadiq, I. M., Ferguson, C. M., Lerman, A., Textor, S. C., Lerman, L. O., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30146 · Cited by 4
Beloborodova, A. V., Морозова, Т. Е., & Em, S. (2010) · PubMed · Cited by 2
[Treatment of dyslipidemia in patients with metabolic syndrome and chronic kidney disease].
Monhart, V. (2009) · PubMed · Cited by 2
Measuring the Effects of Berberine on Serum Prooxidant–Antioxidant Balance in Metabolic Syndrome
Jamialahmadi, T., Guest, P. C., Tasbandi, A., Al‐Rasadi, K., & Sahebkar, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1558-4_22 · Cited by 2
Research works printed but not linked: 1
- Alexander, 2009, Singh AK.Kidney Pathological Changes in Metabolic Syndrome: A Cross-Sectional Study, Am J Kidney Dis, 5, 10.1053/j.ajkd.2009.01.255 · DOI
Cited by
Sorted by citations
The Role of Inflammation in CKD
Kadatane, S., Satariano, M., Massey, M., Mongan, K., & Raina, R. (2023) · Cells · doi:10.3390/cells12121581 · Cited by 350
Association of metabolic syndrome and chronic kidney disease
Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155
Xie, K., Cao, H., Ling, S., Zhong, J., Chen, H., Chen, P., & Huang, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1526482 · Cited by 124
Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches
Hamooya, B. M., Siame, L., Muchaili, L., Masenga, S. K., & Kirabo, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1661603 · Cited by 117
The Metabolic Syndrome, a Human Disease
Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 86
Metadata
- Authors
- Lin, L., Tan, W., Pan, X., Tian, E., Wu, Z., & Yang, J.
- Affiliations
- Chongqing Medical University (CN)
- People's Hospital of Kaizhou District (CN)
- Corresponding author
- Yang, Jurong
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-23
- Volume
- 13
- Pages
- 904001-904001
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC9261267
- OpenAlex
- W4283317650
- Cited by
- 139
- References
- 162
- Citations by year
- 2026: 27 · 2025: 51 · 2024: 37 · 2023: 22 · 2022: 2
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- metabolic syndrome, chronic kidney disease, kidney injury, visceral obesity, hyperglycemia, dyslipidemia, hypertension, glomerular hyperfiltration, renin-angiotensin-aldosterone system, microalbuminuria, podocyte injury, renal fibrosis, insulin resistance, oxidative stress, endothelial dysfunction, endoplasmic reticulum stress, gut microbiota, mesenchymal stem cells, podocyte apoptosis
- MeSH terms
- Humans, Hyperglycemia, Hypertension, Kidney, Metabolic Syndrome, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review

